The SQUID Trial for the Embolization of the Middle Meningeal Artery (STEM) for Treatment of Chronic Subdural Hematoma
Brief description of study
The purpose of this research study is to study the safety and efficacy of embolization (how well it works) to treat middle meningeal artery (MMA) bleeds using SQUID, a liquid particle embolic agent.
Clinical Study Identifier: s21-01641
ClinicalTrials.gov Identifier: NCT04410146
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
